Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas

Nikhil P. Mankuzhy, Brandon S. Imber, Paige Pammer, Beatrice Fregonese, Adriana Cajo, Gustav Cederquist, Alexandra Dreyfuss, Kaitlyn Lapen, Roshal R. Patel, Zachary R. Moore, Carla Hajj, Gilles Salles, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 3040.

https://doi.org/10.1182/blood-2024-208916

Published: 2024

Journal Articles

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 4491.

https://doi.org/10.1182/blood-2023-190326

Published: 2023

Journal Articles

Upfront Radiation Therapy (RT) for Post-Stem Cell Transplant Multiple Myeloma (MM) Patients with Oligo-Relapse/Progressive Disease: Factors Associated with Favorable Outcomes

Beatrice Fregonese, Brandon S. Imber, Alexandra Dreyfuss, Carla Hajj, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 4719.

https://doi.org/10.1182/blood-2023-190770

Published: 2023

Journal Articles

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Gustav Cederquist, Kathryn Tringale, Carla Hajj, Harper Hubbeling, Jennifer Ma, Alexandra Dreyfuss, Beatrice Fregonese, Gilles Salles, Christian Grommes, Michael Scordo, Lorenzo Falchi, Joachim Yahalom, Brandon S. Imber

Blood (2023) 142 (Supplement 1): 1759.

https://doi.org/10.1182/blood-2023-190236

Published: 2023

Journal Articles

Recent Patterns of Radiotherapy Use in Multiple Myeloma: Clinical Outcomes and Possible Radiologic, Biochemical, and Genomic Correlates of Response

Alexandra Dreyfuss, Beatrice Fregonese, Jennifer Ma, Reith R Sarkar, Gustav Cederquist, Saad Z Usmani, Carla Hajj, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6648.

https://doi.org/10.1182/blood-2023-188172

Published: 2023

Journal Articles

Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients

Beatrice Fregonese, Carla Hajj, Silvano Gonzalez, Jisun Lee, Lily Boe, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6281.

https://doi.org/10.1182/blood-2023-190688

Published: 2023

Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2023-185338

Published: 2023

Journal Articles

Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma

Neil Ari Wijetunga, Emily S. Lebow, Jisun Lee, Beatrice Fregonese, Kathryn R. Tringale, Harper Hubbeling, Reith Sarkar, Jennifer Ma, Venkatraman Seshan, Erel Joffe, Ahmet Dogan, Alexander Chan, Guido Wendel, Carla Hajj, Brandon S. Imber, Joachim Yahalom

Blood (2022) 140 (Supplement 1): 6413–6414.

https://doi.org/10.1182/blood-2022-169501

Published: 2022

Journal Articles

Predictors of Response to Radiation Therapy and of Progression to Multiple Myeloma in Patients with Solitary Bone and Extramedullary Plasmacytomas

Beatrice Fregonese, Alexandra Dreyfuss, Jisun Lee, Brandon S. Imber, Joachim Yahalom, Carla Hajj

Blood (2022) 140 (Supplement 1): 10104–10105.

https://doi.org/10.1182/blood-2022-169633

Published: 2022

Journal Articles

Initial Treatment Response Is Prognostic and Predictive of Relapse Patterns: Outcomes of >500 Patients Treated for Primary CNS Lymphoma

Kathryn R. Tringale, Joachim Yahalom, Michael Scordo, Gustav Y Cederquist, Behroze Vachha, Lauren Schaff, Carla Hajj, Harper Hubbeling, Zhigang Zhang, Charlie White, Christian Grommes, Brandon S. Imber

Blood (2022) 140 (Supplement 1): 1336–1337.

https://doi.org/10.1182/blood-2022-164663

Published: 2022

Journal Articles

Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review

Jennifer Ma, Remy Daou, Josiane Bou Eid, Jisun Lee, Beatrice Fregonese, Joe El-Khoury, Neil Ari Wijetunga, Harper Hubbeling, Kathryn R. Tringale, Emily S. Lebow, Reith Sarkar, Brandon S. Imber, Joachim Yahalom, Carla Hajj

Blood (2022) 140 (Supplement 1): 11949–11950.

https://doi.org/10.1182/blood-2022-162623

Published: 2022

Journal Articles

Radiotherapy for Secondary CNS Lymphoma: Patterns of Utilization and Clinical Outcomes

Gustav Y Cederquist, Kathryn R. Tringale, Carla Hajj, Harper Hubbeling, Beatrice Fregonese, Jisun Lee, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon S. Imber

Blood (2022) 140 (Supplement 1): 6683–6684.

https://doi.org/10.1182/blood-2022-170191

Published: 2022

Journal Articles

Safety and Efficacy of Splenic Irradiation for Non-Hodgkin Lymphoma

Harper Hubbeling, Brandon S. Imber, N. Ari Wijetunga, Kathryn R. Tringale, Carla Hajj, Joachim Yahalom

Blood (2022) 140 (Supplement 1): 9538–9539.

https://doi.org/10.1182/blood-2022-167084

Published: 2022

Journal Articles

"Big Boom" (4 Gy x 1) Radiation Treatment (RT) Versus "Big Boom" (2 Gy x 2) for Non-Hodgkin Lymphoma (NHL)

Carla Hajj, Emily S. Lebow, Jisun Lee, Beatrice Fregonese, N. Ari Wijetunga, Harper Hubbeling, Kathryn R. Tringale, Morgan E. Freret, Brandon S. Imber, Joachim Yahalom

Blood (2022) 140 (Supplement 1): 3622–3623.

https://doi.org/10.1182/blood-2022-160246

Published: 2022

Journal Articles

Metabolic Tumor Volume and Total Lesion Glycolysis Can Predict Response to Very Low Dose Radiotherapy (4 Gy) in Indolent B-Cell Lymphomas

N. Ari Wijetunga, Brandon S. Imber, Jisun Lee, Carla Hajj, Marius E Mayerhoefer, Heiko Schoder, Joachim Yahalom

Blood (2021) 138 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2021-151760

Published: 2021

Journal Articles

Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

Blood (2021) 138 (Supplement 1): 2507.

https://doi.org/10.1182/blood-2021-151179

Published: 2021

Journal Articles

Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

Blood (2021) 138 (Supplement 1): 1429.

https://doi.org/10.1182/blood-2021-149702

Published: 2021

Journal Articles

Radiation Therapy for Patients with Diffuse Large B Cell Richter's Syndrome of CLL

Guilherme Sacchi De Camargo Correia, Brandon S. Imber, Carla Hajj, Meghan C. Thompson, Anthony R. Mato, Joachim Yahalom, Lindsey E. Roeker

Blood (2021) 138 (Supplement 1): 1565.

https://doi.org/10.1182/blood-2021-153771

Published: 2021

Journal Articles

Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas

Brandon S. Imber, MD MA, Miguel-Angel Perales, MD, Jessica Flynn, BS, Josel D Ruiz, MPH, Sean Devlin, PhD, Ana Alarcon Tomas, MD, Carla Hajj, MD, Connie Lee Batlevi, MDPhD, Parastoo B. Dahi, MD, Richard J Lin, MDPhD, Jae H. Park, MD, Michael Scordo, MD, Gunjan L. Shah, MDMS, Sergio A. Giralt, MD, Craig S. Sauter, MD, M. Lia Palomba, MD, Joachim Yahalom, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-140991

Published: 2020

Journal Articles

Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy

Karen Chau, BA, Brandon Imber, MD MA, Erel Joffe, MDMSc, Joanna C. Yang, MD, Monica Chelius, BS, Connor Doyle, Carla Hajj, MD, Joachim Yahalom, MD

Blood (2019) 134 (Supplement_1): 2827.

https://doi.org/10.1182/blood-2019-132275

Published: 2019

NARROW

Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Upfront Radiation Therapy (RT) for Post-Stem Cell Transplant Multiple Myeloma (MM) Patients with Oligo-Relapse/Progressive Disease: Factors Associated with Favorable Outcomes

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Recent Patterns of Radiotherapy Use in Multiple Myeloma: Clinical Outcomes and Possible Radiologic, Biochemical, and Genomic Correlates of Response

Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma

Predictors of Response to Radiation Therapy and of Progression to Multiple Myeloma in Patients with Solitary Bone and Extramedullary Plasmacytomas

Initial Treatment Response Is Prognostic and Predictive of Relapse Patterns: Outcomes of >500 Patients Treated for Primary CNS Lymphoma

Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review

Radiotherapy for Secondary CNS Lymphoma: Patterns of Utilization and Clinical Outcomes

Safety and Efficacy of Splenic Irradiation for Non-Hodgkin Lymphoma

"Big Boom" (4 Gy x 1) Radiation Treatment (RT) Versus "Big Boom" (2 Gy x 2) for Non-Hodgkin Lymphoma (NHL)

Metabolic Tumor Volume and Total Lesion Glycolysis Can Predict Response to Very Low Dose Radiotherapy (4 Gy) in Indolent B-Cell Lymphomas

Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

Radiation Therapy for Patients with Diffuse Large B Cell Richter's Syndrome of CLL

Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas

Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only